Market Research Logo

Global Cancer Pain Therapeutics Market 2015-2019

Global Cancer Pain Therapeutics Market 2015-2019

About Cancer Pain Therapeutics

Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.

Technavio’s analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.

The market is divided into the following segments based on region:

  • Americas: The US, Canada, Mexico, and Brazil
  • EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
  • APAC: Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • BioDelivery Sciences
  • ProStrakan Group
  • Teva Pharmaceuticals
  • Yamaha
Other prominent vendors
  • Daiichi Sankyo
  • Eli-lilly
  • Galena Biopharma
  • Grunenthal Group
  • GW Pharmaceuticals
  • Hospira
  • Johnson & Johnson
  • Meda Pharmaceuticals
  • Orexo
  • Sanofi
  • Sorrento Therapeutics
  • WEX Pharmaceuticals
Market driver
  • Unmet medical needs
  • For a full, detailed list, view our report
Market challenge
  • Off-label drug use
  • For a full, detailed list, view our report
Market trend
  • Increase in awareness
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Cancer Pain Therapeutics Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Cancer Pain Therapeutics Market: BioDelivery Sciences, ProStrakan Group and Teva Pharmaceuticals

Other Prominent Vendors in the market are: Daiichi Sankyo, Eli-lilly, Galena Biopharma, Grunenthal Group, GW Pharmaceuticals, Hospira, Johnson & Johnson, Meda Pharmaceuticals, Orexo, Sanofi, Sorrento Therapeutics, and WEX Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “At present, the cancer pain therapeutics market has Teva Pharmaceuticals, BioDelivery Sciences, and ProStrakan Group as the key players. Teva Pharmaceutical's Actiq and Fentora; and ProStrakan's Abstral and Lazanda compete directly with BioDelivery Sciences' Onsolis. To overcome the severe competition being posed, the key players and other vendors have started differentiating their drugs in an attempt to increase profits and avoid price competition.”

According to the report, the major driving factor for the global cancer pain therapeutics market is the high unmet need for appropriate drugs in the market.

Further, the report states that the use of off-label drugs is another important challenge for the market.

Companies Mentioned

BioDelivery Sciences, ProStrakan Group, Teva Pharmaceuticals, Daiichi Sankyo, Eli-lilly, Galena Biopharma, Grunenthal Group, GW Pharmaceuticals, Hospira, Johnson & Johnson, Meda Pharmaceuticals, Orexo, Sanofi, Sorrento Therapeutics, WEX Pharmaceuticals.

  • Executive summary
    • Highlights
    • Scope of the report
    • Market overview
  • Top-vendor offerings
    • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Disease overview
    • Understanding the disease
      • Table Classification of cancer pain
    • Signs and symptoms
      • Table Acute pain syndromes
      • Table Chronic pain syndromes
    • Causes of cancer pain
      • Table Causes of pain from cancer
      • Table Causes of pain from procedures and surgery
      • Table Causes of pain from other cancer treatments
      • Table Common causes of pain in cancer patients
    • Assessment of cancer pain
      • Table Cancer pain assessment
      • Table Types of pain scales
    • Treatment
      • Table Treatment options for cancer pain
      • Table Commonly used non-opioids for pain management
      • Table Commonly used adjuvant medicines for cancer pain
      • Table Management of cancer pain
    • Epidemiology
  • Pipeline portfolio
    • Table Pipeline molecules for cancer pain therapeutics market
    • Information on pipeline candidates
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global cancer pain therapeutics market ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Global cancer pain therapeutics market by drug class
    • Opioids
    • Non-steroidal anti-inflammatory drugs
    • Others
  • Geographical segmentation
    • Table Global cancer pain therapeutics market by geographical segmentation 2014
    • Table Cancer pain therapeutics market in different regions, 2014-2019 ($ millions)
    • Cancer pain therapeutics market in Americas
      • Table Cancer pain therapeutics market in the Americas 2014-2019 ($ millions)
    • Cancer pain therapeutics market in EMEA
      • Table Cancer pain therapeutics market in EMEA 2014-2019 ($ millions)
    • Cancer pain therapeutics market in APAC
      • Table Cancer pain therapeutics market in APAC 2014-2019 ($ millions)
  • Market drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
    • Market analysis 2014
      • Table BioDelivery Sciences: Key takeaways
      • Table ProStrakan: Key takeaways
      • Table Teva Pharmaceuticals: Key takeaways
  • 0Vendor landscape
    • Other prominent vendors
  • Key vendor analysis
    • BioDelivery Sciences
      • Table BioDelivery Sciences: Product pipeline
    • ProStrakan
    • Teva Pharmaceuticals
      • Table Teva Pharmaceuticals: Business segmentation by revenue 2014
      • Table Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Teva Pharmaceuticals: Geographical segmentation by revenue 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report